TORONTO AND BANNOCKBURN, IL, March 26, 2014 /PRNewswire/ - Concordia Healthcare Corp. (Concordia or the Company) (TSX:CXR) (OTCQX: CHEHF) announced today that its subsidiary Pinnacle Biologics, Inc.
Concordia Healthcare Corp. (Concordia) announced that its subsidiary Pinnacle Biologics, Inc. (Pinnacle), a biopharmaceutical research and development company specializing in rare diseases, was ...
Concordia Healthcare Corp. today announced that its subsidiary Pinnacle Biologics, Inc. was granted FDA premarket supplemental approval for the redesigned flexible fiber of its photodynamic therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback